|
| Exchange Received Time 21/06/2018 19:39:37 Exchange Disseminated Time 21/06/2018 19:39:40 Time Taken 00:00:03 | We confirm that further to our announcement dated June 13, 2018, today the Company has entered into a
business transfer agreement (BTA ) with Merck Life Science Private Limited (MLSPL) for the transfer of
the Company''s biopharma (BP), performance materials (PM) and life science (LS) businesses to MLSPL
and/or its affiliates. Pursuant to and in connection therewith, today the Company has also entered into an
agreement with MLSPL, Merck Specialities Private Limited (MSPL) and Merck Performance Materials
Private Limited (MPMPL) for the said direct transfer of the BP and PM businesses to MSPL and MPMPL
respectively, in accordance with the terms and conditions of the BT A. MSPL and MPMPL are affiliates of
MLSPL, all three entities being subsidiaries of the Company''s ultimate holding company, Merck KGaA,
Dannstadt, Germany.
The completion of the business transfer under the aforementioned agreements is subject to certain closing
conditions including receipt of regulatory approvals. |
|
|